Stassets Investment

The firm focuses on the healthcare sector and specializes in early stage investments.  Main target area of interest is in pharmaceuticals, diagnostics/medical devices, digital healthcare but we also actively consider opportunities in the cosmeceuticals and nutraceuticals.    

Our vision is to become the investment firm most preferred by investors and venture companies.  To do so, we strive to identify world-class ideas and technology breakthroughs in healthcare.  At the same time, prudent capital allocation and trend-sensitive risk management is thought out and executed.  We have also assembled the best internal and external teams to proactively guide portfolio companies through uncharted and perilous stages of growth. 

Our founders and investment professionals were educated at Korean & US institutions and possess extensive experience and in the domestic and global healthcare industry.

Stassets Investment is currently managing about 230 Billion KRW in AUM which is spread across three blind funds and six project funds. To date, Stassets has fully liquidated one fund with an IRR of 116% and expects to liquidate more funds in the next few years.  The list of Limited Partners of the funds boasts top tier financial institutions and strategic investors with most of them participating in multiple funds. 

The firm, after extensive research and deliberation, has selectively invested in 17 companies. Most of the portfolio companies are in the healthcare sector and encompass biotech, diagnostics, medical device & instruments and digital healthcare. Stassets expects to diversify its portfolio in the newer vintage funds.

As we are constantly updating the website, we welcome you to revisit us in the near future!

Thank you!